Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Impact of Airborne Pollutants on Stroke.

Khoja A, Kazim F.

Ochsner J. 2018 Winter;18(4):292. doi: 10.31486/toj.18.5004. No abstract available.

2.

Effect on CD4 T-cell count of replacing protease inhibitors in patients with successful HIV suppression: a meta-analysis.

Owen C, Kazim F, Badley AD.

AIDS. 2004 Mar 5;18(4):693-5. No abstract available.

PMID:
15090777
3.
4.

Dose-effect relationship of the beta-agonists fenoterol and salbutamol in patients with asthma.

Newhouse MT, Dolovich MB, Kazim F.

Chest. 1994 Jun;105(6):1738-42.

PMID:
8205869
5.

Definition and measurement of restenosis after successful coronary angioplasty: implications for clinical trials.

Lespérance J, Bourassa MG, Schwartz L, Hudon G, Laurier J, Eastwood C, Kazim F.

Am Heart J. 1993 May;125(5 Pt 1):1394-408. Review.

PMID:
8480594
6.

Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty.

Bourassa MG, Lespérance J, Eastwood C, Schwartz L, Côté G, Kazim F, Hudon G.

J Am Coll Cardiol. 1991 Aug;18(2):368-76.

7.

The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty.

Schwartz L, Lesperance J, Bourassa MG, Eastwood C, Kazim F, Arafah M, Ganassin L.

Am Heart J. 1990 Feb;119(2 Pt 1):232-6.

PMID:
2405609
8.

Prevention of acute complications after percutaneous transluminal coronary angioplasty.

Bourassa MG, Schwartz L, Lespérance J, Eastwood C, Kazim F.

Thromb Res Suppl. 1990;12:51-8.

PMID:
2082488
9.

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.

Schwartz L, Bourassa MG, Lespérance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR.

N Engl J Med. 1988 Jun 30;318(26):1714-9.

PMID:
2967433
10.

Frequent administration by inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma in children.

Reisman J, Galdes-Sebalt M, Kazim F, Canny G, Levison H.

J Allergy Clin Immunol. 1988 Jan;81(1):16-20.

PMID:
2963059
11.

A controlled trial of ambroxol in chronic bronchitis.

Guyatt GH, Townsend M, Kazim F, Newhouse MT.

Chest. 1987 Oct;92(4):618-20.

PMID:
3308343
12.

Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromide.

Dolovich J, Kennedy L, Vickerson F, Kazim F.

J Allergy Clin Immunol. 1987 Sep;80(3 Pt 1):274-8.

PMID:
2957416
13.

Preservation of platelets and blood products by intravenously administered dipyridamole in patients who undergo coronary artery bypass grafting.

Reilly PA, Thompson M, Bayer A, Kazim F, Rosenfeld J, Glynn MF.

Can J Surg. 1987 Jul;30(4):260-4.

PMID:
3496948
14.

A trial of intranasal Atrovent versus placebo in the treatment of vasomotor rhinitis.

Knight A, Kazim F, Salvatori VA.

Ann Allergy. 1986 Nov;57(5):348-54.

PMID:
2946252
15.

Determination of dose-response relationship for nebulized ipratropium in asthmatic children.

Davis A, Vickerson F, Worsley G, Mindorff C, Kazim F, Levison H.

J Pediatr. 1984 Dec;105(6):1002-5. No abstract available.

PMID:
6239021
16.

Dose-response characteristics of nebulized fenoterol in asthmatic children.

Reilly PA, Yahav J, Mindorff C, Kazim F, Levison H.

J Pediatr. 1983 Jul;103(1):121-6.

PMID:
6864377
17.

Effect of administration technique on bronchodilator response to fenoterol in a metered-dose inhaler.

Rivlin J, Mindorff C, Levison H, Kazim F, Reilly P, Worsley G.

J Pediatr. 1983 Mar;102(3):470-2. No abstract available.

PMID:
6827424
18.

Prognostic factors in T3 glottic cancer.

Harwood AR, Deboer G, Kazim F.

Cancer. 1981 Jan 15;47(2):367-72.

PMID:
7459825

Supplemental Content

Support Center